A new Cochrane review casts doubt on the value of ketamine and other N-methyl-D-aspartate (NMDA) receptor agonists to relieve chronic noncancer pain. “Clinicians should know that there is currently no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback